Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens

Final appraisal determination

Final appraisal determination document (PDF 327 KB)

Committee papers (PDF 19.61 MB)

Committee papers Clinical presentation slides (PDF 431 KB)

Committee papers Cost presentation slides (PDF 1.19 MB)

Final scope (PDF 120 KB)

Final matrix (PDF 95 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 134 KB)

Equality impact assessment (Scoping) (PDF 120 KB)

Final scope updated scope (PDF 121 KB)

Draft scope (post-referral) (PDF 127 KB)

Provisional matrix (post-referral) (PDF 95 KB)

Final appraisal determination document (PDF 342 KB)

Committee papers TA250 (PDF 3.01 MB)

: Appeal letter (PDF 498 KB)

: Scrutiny letter (PDF 256 KB)

: Response to scrutiny letter (PDF 318 KB)

: Final scrutiny letter (PDF 217 KB)

Appeal decision TA250 (PDF 235 KB)

Appraisal consultation document TA250 (PDF 206 KB)

Committee papers TA250 (PDF 6.51 MB)

Final scope TA250 (PDF 51 KB)

Final matrix TA250 (PDF 58 KB)

NICE's response to comments on the draft scope and provisional matrix TA250 - Draft scope (PDF 147 KB)

NICE's response to comments on the draft scope and provisional matrix TA250 - Draft Matrix (PDF 39 KB)